Used in pharmaceutical research as a key intermediate in the synthesis of centrally acting agents, particularly those targeting neurological pathways. Its structural features make it suitable for developing compounds with activity toward dopamine and serotonin receptors. It has been explored in the design of ligands for positron emission tomography (PET) imaging, aiding in the study of brain function and neurodegenerative diseases. Additionally, derivatives of this compound show potential in the development of treatments for depression, anxiety, and addiction due to their ability to modulate neurotransmitter systems. Its rigid bicyclic framework enhances selectivity and metabolic stability in drug candidates.